Lasa Supergenerics Limited (NSE:LASA)
India · Delayed Price · Currency is INR 7.20
+0.21 (3.00%)
Aug 21, 2026, 3:28 PM IST
Lasa Supergenerics Market Cap
Lasa Supergenerics has a market cap or net worth of 360.73 million as of August 21, 2026. Its market cap has decreased by -23.89% in one year.
Market Cap
360.73M
Enterprise Value
451.23M
Revenue
65.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.20
ChartMarket Cap Chart
Since September 22, 2017, Lasa Supergenerics's market cap has decreased from 3.53B to 360.73M, a decrease of -89.79%. That is a compound annual growth rate of -22.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 360.73M | -23.73% |
| Dec 31, 2025 | 472.96M | -62.89% |
| Dec 31, 2024 | 1.27B | -14.92% |
| Dec 29, 2023 | 1.50B | 9.45% |
| Dec 30, 2022 | 1.37B | -50.95% |
| Dec 31, 2021 | 2.79B | -18.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 11.04B |
| Amanta Healthcare | 6.10B |
| Bafna Pharmaceuticals | 5.74B |
| Valiant Laboratories | 4.99B |
| Nectar Lifesciences | 2.04B |
| Brooks Laboratories | 1.78B |
| Balaxi Pharmaceuticals | 1.31B |
| Alpa Laboratories | 1.31B |